Antibodies
CNY 3650.00
5周
Cytokeratin 14 (KRT14) mouse monoclonal antibody, clone LL002, FITC
| Applications | FC, IF |
| Reactivities | Human |
CNY 9225.00
4周
HLA class I B-27 alpha / HLA-B27 mouse monoclonal antibody, clone HLA-ABC-m3, FITC
| Applications | FC |
| Reactivities | Human |
Human IgG (F(ab)2 specific) goat polyclonal antibody, FITC
| Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of free of Ig bound subunits of both kappa and lambda type. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/20-1/80. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
| Reactivities | Human |
| Conjugation | FITC |
LOC104968698 mouse monoclonal antibody, clone S100217, FITC
| Applications | FC, IF, IHC |
| Reactivities | Bovine, Human, Mouse, Rat |
LOC104968698 mouse monoclonal antibody, clone S100217, FITC
| Applications | FC, IF, IHC |
| Reactivities | Bovine, Human, Monkey, Mouse, Rat |
Human IgM mouse monoclonal antibody, clone NI 179, FITC
| Applications | To identify the presence of IgM in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as direct and indirect Immunofluorescence staining of cytoplasmic IgM and cell membrane IgM. General Recommended Dilutions: Histochemical Use: 1/10-1/50 |
| Reactivities | Human |
| Conjugation | FITC |
Human IgA1 mouse monoclonal antibody, clone NI 69-11 (A89-036), FITC
| Applications | To identify the presence of IgA1 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as Immunofluorescence staining of cytoplasmic IgA1, and Immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/20-1/100. Western blot: 1/200 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
Lactoferrin (LTF) mouse monoclonal antibody, clone NI 25, FITC
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
CNY 9630.00
5周
Human IgG3 (F(ab)2 specific) mouse monoclonal antibody, clone NI 330 (HP 6050), FITC
| Applications | To identify the presence of IgG3 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect Immunoperoxidase staining of cytoplasmic IgG3, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50 ELISA: from 1/200 upwards Western blot: from 1/400 upwards |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9630.00
5周
Human IgG (Isotype Specific) mouse monoclonal antibody, clone NI 335 and NI 343, FITC
| Applications | To identify the presence of IgG in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50 ELISA: from 1/200 upwards Western blot: from 1/400 upwards |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9630.00
5周
Human IgG4 (pFC specific) mouse monoclonal antibody, clone NI 315 (HP 6206), FITC
| Applications | To identify the presence of IgG4 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG4, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9630.00
5周
Human IgG2 (F(ab)2 specific) mouse monoclonal antibody, clone NI 6014 (HP 6014), FITC
| Applications | To identify the presence of IgG2 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG2, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9630.00
5周
Human IgG1 (Fc specific) mouse monoclonal antibody, clone NI 132 (HP 6186), FITC
| Applications | To identify the presence of IgG1 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG1, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
活动过滤器
优化搜索结果
Target Symbol
- PTPRC (5)
- CD19 (4)
- CD3E (4)
- ITGAM (4)
- MAP2K2 (4)
- MAPK1 (4)
- CD14 (3)
- CD34 (3)
- CD4 (3)
- CD44 (3)
- CD45 (3)
- CD9 (3)
- CR2 (3)
- GYPA (3)
- ITGAE (3)
- ITGB2 (3)
- SELL (3)
- SPN (3)
- BCL3 (2)
- C1QA (2)
- CD151 (2)
- CD1A (2)
- CD200 (2)
- CD21 (2)
- CD24 (2)
- CD40 (2)
- CD55 (2)
- CD62E (2)
- CD81 (2)
- CD8A (2)
- CEACAM5 (2)
- DCR1 (2)
- ENG (2)
- FAS (2)
- FCGR2A (2)
- FCGR3A (2)
- GLYCOPHORIN A (2)
- GP9 (2)
- HLA-B (2)
- HLA-G (2)
- ICAM1 (2)
- IFNG (2)
- IL2 (2)
- ITGA2B (2)
- ITGB3 (2)
- LACTOFERRIN (2)
- MAP2K1 (2)
- MME (2)
- PECAM1 (2)
- PRTN3 (2)
- S100A1 (2)
- TEK (2)
- TFRC (2)
- THY1 (2)
- TLR2 (2)
- TLR4 (2)
- TNFRSF1B (2)
- VCAM1 (2)
- ADGRE3 (1)
- AKT1 (1)
- AKT3 (1)
- ALB (1)
- ASGR1 (1)
- B7-2 (1)
- C-MYC (1)
- C3 (1)
- C5AR1 (1)
- C5R1 (1)
- C9 (1)
- CCR5 (1)
- CD1 (1)
- CD101 (1)
- CD11A (1)
- CD13 (1)
- CD130 (1)
- CD16 (1)
- CD162 (1)
- CD177 (1)
- CD1B (1)
- CD2 (1)
- CD20 (1)
- CD209 (1)
- CD226 (1)
- CD23 (1)
- CD247 (1)
- CD28 (1)
- CD31 (1)
- CD33 (1)
- CD40L (1)
- CD40LG (1)
- CD43 (1)
- CD46 (1)
- CD48 (1)
- CD5 (1)
- CD52 (1)
- CD53 (1)
- CD58 (1)
- CD59 (1)
- CD62L (1)
- CD63 (1)
Antibody Hosts
Isotypes
Clonalities
Families
- Druggable Genome (63)
- Transmembrane (57)
- ES Cell Differentiation/IPS (28)
- Secreted Protein (18)
- Adult stem cells (6)
- Transcription Factors (5)
- Embryonic stem cells (4)
- Protease (4)
- Cancer stem cells (3)
- Phosphatase (3)
- Induced pluripotent stem cells (2)
- GPCR (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cell adhesion molecules (CAMs) (25)
- Hematopoietic cell lineage (22)
- Cytokine-cytokine receptor interaction (14)
- Natural killer cell mediated cytotoxicity (13)
- T cell receptor signaling pathway (12)
- Primary immunodeficiency (10)
- Systemic lupus erythematosus (10)
- Allograft rejection (9)
- Jak-STAT signaling pathway (7)
- Type I diabetes mellitus (7)
- Viral myocarditis (7)
- Autoimmune thyroid disease (6)
- Complement and coagulation cascades (6)
- Graft-versus-host disease (6)
- Toll-like receptor signaling pathway (6)
- Fc gamma R-mediated phagocytosis (5)
- Apoptosis (4)
- B cell receptor signaling pathway (4)
- Leukocyte transendothelial migration (4)
- Antigen processing and presentation (3)
- Asthma (3)
- ECM-receptor interaction (3)
- Pathways in cancer (3)
- RIG-I-like receptor signaling pathway (3)
- Regulation of actin cytoskeleton (3)
- Small cell lung cancer (3)
- TGF-beta signaling pathway (3)
- Dilated cardiomyopathy (2)
- Endocytosis (2)
- Focal adhesion (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- MAPK signaling pathway (2)
- Pathogenic Escherichia coli infection (2)
- Acute myeloid leukemia (1)
- Adipocytokine signaling pathway (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Axon guidance (1)
- Bladder cancer (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Cytosolic DNA-sensing pathway (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Fc epsilon RI signaling pathway (1)
- Glutathione metabolism (1)
- Lysosome (1)
- Metabolic pathways (1)
- NOD-like receptor signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Prion diseases (1)
- Proteasome (1)
- Regulation of autophagy (1)
- Renin-angiotensin system (1)
- Thyroid cancer (1)
- Type II diabetes mellitus (1)
- Wnt signaling pathway (1)
